What is PharmChem, Inc. (PCHM)?

PharmChem, Inc. (PCHM) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of PCHM?

The current price of PCHM is $3.75. Prices are updated in real time on Stocks360.

What is PCHM's price-to-earnings (PE) ratio?

PCHM's trailing twelve-month PE ratio is 12.50, based on current price and earnings per share data available on Stocks360.

What is PCHM's market capitalization?

PCHM's market capitalization is $21,950,509.00, placing it in the small-cap tier.

PharmChem, Inc. (PCHM)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$3.75

Market Cap

$21.95M

PE (TTM)

12.50

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.67

Day Range

$3.74 – $3.75

52-wk Range

$2.95 – $3.98

Avg Volume

N/A

Volume

30.42K

PharmChem, Inc. (PCHM) is a publicly traded company in the Healthcare sector. Latest price: $3.75. Market cap $21.95M. Trailing PE 12.50. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About PharmChem, Inc.

PharmChem, Inc. manufactures and distributes the PharmChek Sweat Patch, a product designed for detecting the presence of illicit substances. This patch uses sweat as its sample source, offering an innovative alternative to conventional urine drug tests for identifying cocaine, opiates, amphetamines, PCP, and marijuana. The company is headquartered in Fort Worth, Texas.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	12.50×
P/S (TTM)	3.61×
P/B	8.11×
PEG	0.16×
P/FCF (TTM)	16.85×
EV / EBITDA	11.70×
EV / Sales	3.35×
Earnings Yield	7.93%
Free Cash Flow Yield	5.93%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$20.37M
Revenue (TTM)	$6.09M
Net Income (TTM)	$1.74M
Free Cash Flow (TTM)	$1.30M
Net Debt	-$1.58M
Working Capital	$2.09M
Gross Margin	63.72%
Operating Margin	27.33%
Net Margin	22.69%
Return on Equity	63.40%
Return on Invested Capital	59.98%